This technical guide evaluates original bremelanotide PT 141, focusing on physical stability, degradation mechanisms during freeze-thaw cycles, and optimal storage parameters for laboratory settings. Designed for principal investigators and bench scientists, this document outlines analytical standards, solvent compatibility, and handling protocols to maintain peptide integrity.
This technical guide evaluates original bremelanotide PT 141, focusing on physical stability, degradation mechanisms during freeze-thaw cycles, and optimal storage parameters for laboratory settings. Designed for principal investigators and bench scientists, this document outlines analytical standards, solvent compatibility, and handling protocols to maintain peptide integrity.
The research compound known as original bremelanotide PT 141 is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). In preclinical models, it functions primarily as a potent melanocortin agonist with target selectivity for the MC3R and MC4R receptor subtypes. Preclinical studies suggest that central nervous system melanocortin-receptor signaling via these pathways is intrinsically linked to sexual-health pathways and neuroendocrine responses, distinguishing it from peripheral vasodilators.
Repeated freeze-thaw cycles present a major physical stressor to reconstituted PT-141 solutions. Freeze-thaw stress induces ice-water interfacial tension, localized concentration spikes (cryoconcentration), and pH fluctuations within the un-frozen liquid micro-domains. These physical conditions promote peptide aggregation, hydrolytic cleavage, and irreversible tertiary conformation shifts. To maintain maximum purity and binding affinity across long-term assays, researchers must implement strict single-use aliquoting protocols immediately following initial reconstitution with appropriate laboratory diluents.
From a structural perspective, original bremelanotide PT 141 is a cyclic lactam heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. The internal lactam bridge provides enhanced metabolic stability against enzymatic cleavage by exopeptidases compared to its linear precursor, alpha-MSH. This cyclic conformation fixes the core pharmacophore (His-D-Phe-Arg-Trp) in an active binding orientation suitable for melanocortin receptor engagement.
In vitro receptor binding assays demonstrate that PT-141 exhibits high affinity for melanocortin-4 receptors (MC4R) and melanocortin-3 receptors (MC3R), with lower affinity for MC1R and minimal binding to MC5R. Unlike peripheral signaling agents, central MC4R activation downstream of PT-141 triggers neuronal signaling pathways in the hypothalamus. Investigations documented in our preclinical research library highlight how these central pathways modulate physiological and behavioral responses in animal models without inducing direct vascular smooth muscle relaxation.
When a reconstituted solution of high-purity peptides undergoes temperature transitions between liquid and frozen states, the formation of ice crystals exerts physical shear stress on the peptide backbone. As water crystallizes, the dissolved peptide and salts are excluded into a shrinking liquid fraction, creating localized zones of extreme ionic strength and altered pH. For PT-141, this cryoconcentration accelerates intermolecular collisions between hydrophobic side chains, resulting in soluble and insoluble oligomer formation.
Furthermore, chemical degradation pathways like deamidation, methionine oxidation, and lactam ring hydrolysis occur at elevated rates if the reconstituted solution remains at temperatures above -20°C for extended periods. Data derived from reversed-phase high-performance liquid chromatography (RP-HPLC) demonstrate that PT-141 subjected to five consecutive unbuffered freeze-thaw cycles exhibits a measurable decrease in monomeric purity, accompanying a corresponding rise in high-molecular-weight aggregate peaks. Minimizing thermal cycling is therefore vital for maintaining uniform binding kinetics in cell assays.
To achieve optimal physical stability, reconstitution protocols must account for solvent ionic strength, pH, and preservative additions. Standard laboratory reconstitutions utilize sterile 0.9% sodium chloride, bacteriostatic water containing 0.9% benzyl alcohol, or phosphate-buffered saline (PBS) adjusted to a physiological pH range of 6.5 to 7.4. Detailed solvent matrices are analyzed in our guide to reconstitution solutions.
Lyophilized PT-141 cake should be reconstituted by allowing the diluent to trickle slowly down the inner glass wall of the vial, followed by gentle swirling. Direct impingement of the liquid jet onto the lyophilized powder must be avoided, as high shear forces induce bubble formation and surface denaturation. Vigorously shaking the vial causes hydrophobic regions of the peptide to aggregate at air-water interfaces, destabilizing the cyclic structure prior to freezer storage.
The shelf-life and chemical stability of original bremelanotide PT 141 depend strictly on moisture content and temperature control. In its lyophilized powder form, PT-141 remains stable at -20°C for up to 24 months, provided the vial is sealed under an inert gas matrix and protected from light exposure. Desiccant packs should be kept in primary storage containers to prevent moisture uptake, which initiates slow hydrolytic degradation even at sub-zero temperatures.
Once reconstituted into liquid phase, the peptide's shelf life decreases significantly. Reconstituted PT-141 maintained at 2°C to 8°C should be utilized within 14 to 30 days depending on the presence of antimicrobial preservatives. If long-term utility of the solution is required across multiple test dates, the working solution should be immediately divided into single-use micro-aliquots in polypropylene tubes and stored at -80°C. This practice eliminates the necessity for repeated freeze-thaw iterations.
Understanding the relative stability and receptor selectivity profiles of melanocortin agonists allows researchers to select appropriate control compounds for comparative studies. Synthetic melanocortin analogs differ in their lipophilicity, net charge, and susceptibility to thermal degradation based on sequence variation and cyclic constraints.
For instance, Melanotan II shares a structural lineage with PT-141 but possesses a distinct C-terminal amide modification that alters its receptor cross-reactivity and physical solubility profile in aqueous solutions. In contrast, non-melanocortin research peptides like AOD-9604 and CJC-1295 Dac exhibit entirely different tertiary degradation mechanisms, relying heavily on secondary structure maintenance rather than lactam ring integrity. Evaluating these parameters across a unified experimental design ensures precise attribution of receptor-mediated physiological effects.
Rigorous quality control requires verification of peptide identity, purity, and mass accuracy using orthogonal analytical techniques. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) coupled with ultraviolet (UV) detection at 214 nm separates the target monomer from synthesis impurities, truncated fragments, and oxidation products. A purity threshold of ≥98.0% ensures experimental reproducibility across in vitro binding models.
Mass validation is established using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometry. These techniques confirm the molecular mass of bremelanotide (1024.2 g/mol) and confirm the retention of the cyclic lactam ring. Comprehensive analytical methodologies are detailed in our technical document on analytical purity testing.
PX1 Research maintains stringent manufacturing and analytical benchmarks for all research compounds supplied to academic, clinical, and industrial laboratories. Every lot of original bremelanotide PT 141 undergoes comprehensive third-party testing to guarantee purity, identity, and safety parameters prior to distribution.
Laboratories establishing high-throughput screening platforms or continuous assay schedules can access customized batch sizes and dedicated account oversight through our bulk institutional ordering program. All orders are packed in temperature-controlled packaging and dispatched via same-day shipping (Monday–Friday) from our dual distribution facilities in California and Arizona.
What is the primary mechanism of original bremelanotide pt 141?
Original bremelanotide PT 141 acts as a synthetic melanocortin receptor agonist, exhibiting primary binding selectivity for MC3R and MC4R. Preclinical studies suggest its activation of central nervous system melanocortin signaling pathways directly influences neuroendocrine and sexual-health pathways in laboratory models.
How many freeze-thaw cycles can PT-141 tolerate before degrading?
Analytical assays indicate that PT-141 begins exhibiting aggregate formation and loss of monomer purity after as few as 2 to 3 freeze-thaw cycles. To prevent physical degradation, reconstituted solutions should be aliquoted into single-use volumes prior to freezing at -20°C or -80°C.
What is the recommended solvent for reconstituting PT-141 for long-term storage?
Bacteriostatic water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is recommended. Bacteriostatic water inhibits microbial growth during refrigerated storage, while buffered saline helps maintain optimal pH during sub-zero storage.
How does PT-141 differ structurally from Melanotan II?
While both are cyclic peptides derived from alpha-MSH, PT-141 is a metabolite of Melanotan II that lacks the C-terminal amide group. This structural modification alters its receptor binding profile, reducing MC1R affinity relative to MC4R and MC3R.
What temperature should lyophilized PT-141 be stored at upon arrival?
Lyophilized PT-141 should be stored at -20°C for long-term retention of stability. For short-term storage under 30 days, room temperature (20°C to 25°C) or refrigeration (2°C to 8°C) is acceptable if kept sealed with a desiccant.
What are the endotoxin limits for PX1 Research PT-141?
PX1 Research verifies that all peptide lots contain endotoxin levels strictly below <0.1 EU/mg, as validated by Chromogenic Limulus Amebocyte Lysate (LAL) testing, making them suitable for sensitive cell culture and preclinical assays.
How is PT-141 purity verified by PX1 Research?
Purity is verified using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) to ensure a monomeric purity of ≥98%, alongside Mass Spectrometry (ESI or MALDI-TOF) to confirm correct molecular mass.
Can shaking a reconstituted PT-141 vial cause degradation?
Yes. Vigorously shaking a reconstituted peptide solution creates surface aeration and foam, forcing hydrophobic residues to the air-water interface where they undergo shear-induced aggregation and conformational changes.
What physical signs indicate that a PT-141 solution has degraded?
Visible precipitation, persistent turbidity, color shifts, or persistent particulate matter upon thawing indicate peptide aggregation or microbial contamination. Such solutions should be discarded.
Where does PX1 Research ship PT-141 orders from?
All orders are fulfilled directly from state-of-the-art dispatch facilities located in California and Arizona, offering same-day shipping for orders placed before standard daily cutoffs Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.